UK-based construction company Willmott Dixon has commenced work on two new specialist facilities in Southampton.

Health and care property developer Prime has developed these two new facilities in collaboration with University Hospital Southampton NHS Foundation Trust (UHS).

To be located on plot two of the Adanac Health and Innovation Campus, the facility will include an aseptic pharmacy and sterile services department (SSD) and room for expansion.

The aseptic pharmacy will operate as a Medicines and Healthcare products Regulatory Agency (MHRA)-licensed pharmacy, manufacturing sterile pharmaceuticals for UHS and other NHS providers in the region.

Additionally, the SSD will disinfect surgical instruments and equipment for use by UHS while these services will be provided by strategic provider IHSS at the new facility.

UHS chief pharmacist James Allen said: “As an MHRA-licensed unit, the facility will utilise advances in automation to produce products at scale, enhancing the capacity of patient pathways in UHS and NHS Trusts in Hampshire and neighbouring healthcare systems.”

Macquarie Asset Management has funded this multi-use facility for the financial services company Just Group.

This project is in line with construction projects aimed to expand the UHS.

Following this, the partners have collaborated to deliver the Adanac Health and Innovation Campus, which provides expansion space close to the hospital and convenient access to the highway network.

Prime development director Ewan Forsyth said: “The construction of these facilities will be a major milestone in our partnership with UHS and a big step towards our shared goal of deepening the reputation of Southampton as a centre for medical excellence, preserving clinical space and enriching the local economy.”